ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $20,000 | -86.7% | 428 | -93.0% | 0.00% | – |
| Q1 2019 | $150,000 | +117.4% | 6,151 | +26.8% | 0.00% | – |
| Q4 2018 | $69,000 | +137.9% | 4,850 | +150.6% | 0.00% | – |
| Q3 2018 | $29,000 | -19.4% | 1,935 | -8.8% | 0.00% | – |
| Q2 2018 | $36,000 | 0.0% | 2,122 | -1.7% | 0.00% | – |
| Q1 2018 | $36,000 | +500.0% | 2,159 | +340.6% | 0.00% | – |
| Q4 2017 | $6,000 | -57.1% | 490 | -56.8% | 0.00% | – |
| Q3 2017 | $14,000 | +250.0% | 1,135 | +131.6% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 490 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | -69.2% | 490 | -66.0% | 0.00% | – |
| Q4 2016 | $13,000 | +8.3% | 1,440 | -16.3% | 0.00% | – |
| Q3 2016 | $12,000 | +50.0% | 1,720 | -24.5% | 0.00% | – |
| Q2 2016 | $8,000 | +60.0% | 2,279 | +32.5% | 0.00% | – |
| Q1 2016 | $5,000 | -28.6% | 1,720 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | -53.3% | 1,720 | -48.2% | 0.00% | – |
| Q3 2015 | $15,000 | +25.0% | 3,320 | +93.0% | 0.00% | – |
| Q2 2015 | $12,000 | -7.7% | 1,720 | 0.0% | 0.00% | – |
| Q1 2015 | $13,000 | 0.0% | 1,720 | -38.0% | 0.00% | – |
| Q4 2014 | $13,000 | -68.3% | 2,775 | -75.6% | 0.00% | – |
| Q3 2014 | $41,000 | -21.2% | 11,350 | 0.0% | 0.00% | – |
| Q2 2014 | $52,000 | -1.9% | 11,350 | 0.0% | 0.00% | – |
| Q1 2014 | $53,000 | -7.0% | 11,350 | 0.0% | 0.00% | – |
| Q4 2013 | $57,000 | -20.8% | 11,350 | -1.3% | 0.00% | – |
| Q3 2013 | $72,000 | -8.9% | 11,500 | -34.3% | 0.00% | – |
| Q2 2013 | $79,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|